KevinMarkShannonMD

Professor, Pediatrics, UCSF School of Medicine

Are you Dr. Shannon?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
You already have 23 invites waiting!
Read the latest clinical news, personalized to your specialty.

Office
500 Parnassus Ave Hse302
San Francisco, CA 94143
Phone+1 415-476-7932

Fax+1 415-502-5127

Dr. Kevin Shannon, MD is a pediatric hematologist/oncologist in San Francisco, California. He is currently licensed to practice medicine in California. He is a Professor at UCSF School of Medicine.

University of California (San Francisco)Fellowship, Pediatric Hematology/Oncology, 1985 - 1988
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1979 - 1982
Weill Cornell MedicineClass of 1979, MD

PubMed

8 citations
High-Complexity shRNA Libraries and PI3 Kinase Inhibition in Cancer: High-Fidelity Synthetic Lethality Predictions
Marsilius Mues, Laila Karra, Damia Romero-Moya, Anica M. Wandler, Matthew J. Hangauer
Cell Reports. 2019-04-09
32 citations
MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus.
Peter M K de Blank, Andrea M Gross, Srivandana Akshintala, Jaishri O Blakeley, Gideon Bollag
Neuro-Oncology. 2022-11-02
73 citations
The creatine kinase pathway is a metabolic vulnerability in EVI1-positive acute myeloid leukemia.
Nina Fenouille, Christopher F. Bassil, Issam Ben-Sahra, Lina Benajiba, Gabriela Alexe
Nature Medicine. 2017-03-01

$Trametinib Shows Promise for Children with Relapsed or Refractory JMML$
Trametinib Shows Promise for Children with Relapsed or Refractory JMMLJune 13th, 2024
Cancer Researchers Publish Findings on Rare Childhood LeukemiaOctober 20th, 2015